COVID-19 Related Records
The documents linked on this page have been redacted for certain information that is exempt from disclosure under the Freedom of Information Act, 5 U.S.C. sec. 552.This includes, for example, trade secret information, confidential commercial information, predecisional/deliberative-process information, and personal privacy information. The full text of any published materials within this document collection, including newspaper and journal articles, will not be posted to this website because such material is copyright protected.
- Memorandum Explaining Basis for Declining Request for Emergency Use Authorization for Emergency Use of Fluvoxamine Maleate (PDF) April 29, 2022
- Division of Epidemiology Literature Review HCQ 5.21.20 (PDF) April 29, 2021
- Office of Clinical Pharmacology Consult Review HCQ 5.15.20 (PDF) April 29, 2021
- FAERS Detailed Blumen Hand Sanitizer 022521 1230 (PDF) March 29, 2021
- FAERS Detailed HCQ 031221 1592 (PDF) March 29, 2021
- Memorandum Explaining Basis for Declining Request for Emergency Use Authorization for Emergency Use of Hydroxychloroquine Sulfate (PDF) January 20, 2021
- FAERS Detailed Actemra 111220 7890 (PDF) January 15, 2021
- FAERS Detailed Remdesivir 110320 7763 (PDF) November 16, 2020
- FAERS Detailed AZT 100120 6953 (PDF) October 14, 2020
- FAERS Summary AZT 100120 6593 (XLSX) October 14, 2020
- FAERS Detailed CQ 100120 6953 (PDF) October 14, 2020
- FAERS Summary CQ 100120 6593 (XLSX) October 14, 2020
- FAERS Detailed HCQ 100120 6953 (PDF) October 14, 2020
- FAERS Summary HCQ 100120 6593 (PDF) October 14, 2020
- EUA Clinical Virology Review Remdesevir 050420 for EUA Issued on 050120 (PDF) September 24, 2020
- EUA Review Remdesivir 050120 (PDF) August 31, 2020
- Janet Woodcock emails_testing labs_2020-2623 (PDF) August 21, 2020
- FAERS Detailed Remdesivir 080520 5694 (PDF) August 13, 2020
- FAERS Detailed HCQ 071620 5207 (PDF) August 11, 2020
- IPCA Laboratories removal of HCQ from IA 66-40 4247 (PDF) August 6, 2020
- Leopold et al. v. Center For Disease Control et al., Case No. 20-CV-00722-, CKK_Part 1 (PDF) July 7, 2020
- OSE Review Hydroxychloroquine-Cholorquine 19May2020 Redacted (PDF) July 1, 2020
- EUA Review CQ HCQ (PDF) June 30, 2020
- FAERS Detailed Azithromycin 050520 3535 (PDF) June 30, 2020
- FAERS Detailed CQ 050520 3535 (PDF) June 30, 2020
- FAERS Detailed CQ 051120 3696 (XLSX) June 30, 2020
- FAERS Detailed CQ 060920 3997 (PDF) June 30, 2020
- FAERS Detailed HCQ 040820 2902 (XLSX) June 30, 2020
- FAERS Detailed HCQ 042720 3237 (PDF) June 30, 2020
- FAERS Detailed HCQ 050520 3535 (PDF) June 30, 2020
- FAERS Detailed HCQ 051120 3696 (XLSX) June 30, 2020
- FAERS Detailed HCQ 060320 4185 (PDF) June 30, 2020
- FAERS Detailed HCQ 060920 3997 (PDF) June 30, 2020
- FAERS Detailed Remdesivir 060320 4186 (PDF) June 30, 2020
- FAERS ICRS CQ HCQ (specified) 3588 (PDF) June 30, 2020
- FAERS ICRS ref in 042420 CQ HCQ Drug Safety Communication 3276 (PDF) June 30, 2020
- Declination of Emergency Use Authorization for Sabizabulin 9 mg Capsules (PDF) February 24, 2023
Acronyms:
CQ = Chloroquine
EUA = Emergency Use Authorization
FAERS = FDA Adverse Event Reporting System
HCQ = Hydroxychloroquine
ICRS = Individual Case Reports
Date created: June 25, 2020, updated: March 7, 2023
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
Note: Documents in PDF format require the Adobe Acrobat Reader®.